- Filed
- Jun 12, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Jun 10, 2026 | 12.38M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 11.83M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 10.07M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$363.83K |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$107.59K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $78.59K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $531.28K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $1.11M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $31.26M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $31.86M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $7.05M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $7.38M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $4.61M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $4.55M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $6.2M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $6.2M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $436.72K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $988.23K |
| Total Assets | Q1 2026 · Mar 31, 2026 | $37.45M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $38.06M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.06 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.04 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.06 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.04 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $797.6K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $513.34K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $2.45K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$710.57K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$408.13K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$804.8K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$522.85K |